Showing results (221-230 of 295) with videos related to
Sort By:
Pageof 30
Journal of Gastroenterology and Hepatology|April 11, 2012
Genomic copy number of a carcinogenic single nucleotide polymorphism at 8q24 in non-risk allele colorectal cancer associated with insulin growth factor 2 receptor expressionYusuke Takahashi, Koshi Mimori, Ken Yamamoto, et al.Annals of Surgical Oncology|December 4, 2014
A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808)Hiroyuki Uetake, Masamichi Yasuno, Megumi Ishiguro, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 19, 2008
[Future directions of anticancer drug development in Japan]Hideyuki Akaza, Koji Kawai, Takashi Tsuruo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Distinct gene expression-defined classes of gastrointestinal stromal tumorUmio Yamaguchi, Robert Nakayama, Kazufumi Honda, et al.International Journal of Clinical Oncology|October 18, 2017
A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapyTakako Yanai, Satoru Iwasa, Hironobu Hashimoto, et al.Journal of Bioscience and Bioengineering|July 3, 2013
Identification of a candidate single-nucleotide polymorphism related to chemotherapeutic response through a combination of knowledge-based algorithm and hypothesis-free genomic dataHiro Takahashi, Nahoko Kaniwa, Yoshiro Saito, et al.Surgery|November 23, 2017
Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorizationHideki Ueno, Shigeki Sekine, Taihei Oshiro, et al.Journal of Proteomics|November 29, 2011
Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumorKazutaka Kikuta, Daisuke Kubota, Tsuyoshi Saito, et al.Oncotarget|December 10, 2017
The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapyHirokazu Shoji, Kohei Tada, Shigehisa Kitano, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2002
[Post launch studies]Hideyuki Akaza, Yasuo Ohashi, Yasuhiro Shimada, et al.Pageof 30